The human body is protected against pathogens originating from the external and internal world through a system of innate and acquired immunity, which work together both in healthy and sick subjects. The Toll-like receptors are located on the surface of microglia cells and are involved in the development of neurogenic inflammation, which subsequently leads to the emergence of many diseases and symptoms such as depression, fatigue, chronic and neuropathic pain, cough, constipation and pruritus. The Toll-like receptor activation is inhibited, inter alia, by antidepressants. It is probable that in the near future newer drugs will be known, which will inhibit the development of neurogenic inflammation more efficiently, in order to ensure a more effective treatment of symptoms resistant to standard pharmacotherapy. Med Pract 2019; 13, 2: 57-64 Immunologia dla specjalistów medycyny paliatywnej. Rola receptorów Toll-like w wywoływaniu objawów choroby Artykuł jest tłumaczeniem pracy: Żylicz Z., Immunology for palliative medicine specialists. The role of Toll-like receptors in inducing disease symptoms. Palliat. Med. Pract. 2019 tom 13, nr 2: 57-64. Należy cytować wersję pierwotną. Piśmiennictwo znajduje się na stronach 61-64.
Introduction
Until recently, the statement that a palliative medicine specialist should have knowledge in the field of immunology was considered a misunderstanding. Modern immunology with monoclonal antibodies and many other very expensive but technologically advanced procedures, in some sense, contradicted the principles of palliative medicine. For some time, however, immunologists have been trying to answer questions that are of great interest to the palliative medicine specialists, namely how the symptoms of the disease occur and how they can be treated more effectively. Some drugs have been known for a long time, however, the mechanisms remained unknown. Over the past 10 years, a significant progress in the effectiveness of symptom management has been ob-served. The article is an introduction to immunology for people interested in palliative medicine.
Types of immunity
The human body is protected against harmful, both external and internal, influences by the two types of immune systems. The first one is the Innate Immunity system, and the other is Acquired Immunity. The former system is evolutionarily older and non-specific, formed in the process of evolution. Until now it has been thought to consist only in the passive resistance -epidermal or mucous impermeability barrier for the clearance of bacteria excreted with mucus along with any act of coughing, or diarrhoea, which accelerates the removal of pathogenic bacteria and their toxins from the body. Nevertheless, this system holds many macrophages and other cells in the body that destroy most bacteria and viruses, regardless of their type. In the past this system was considered to be of little interest. The most important is the latter system, of specific or acquired immunity, which is evolutionarily younger and is observed only in mammals. When the body is attacked by bacteria, fungi or viruses, it produces highly specific antibodies or cytotoxic T lymphocytes, which counteract the development of infection. If the system is inefficient, a disease develops. Both innate and acquired immunity systems are also responsible for distinguishing own cells from the foreign ones, which plays an important role in the development of autoimmune diseases and cancers. Both systems interact and support each other. The article mainly discusses the role of the innate immune system.
Intestinal flora (microbiome)
In the human body there are 10 13 -10 14 microbial cells (about 1 kg) that contain 100 times more genes than the human body [1] . These are the cells of bacteria, fungi and viruses that occur on the skin, in the mouth, in the airways and mainly in the digestive tract. This system is referred to as microbiome [2] , which is somehow "an organism in the body", with its own dynamics. If the microbiome is balanced and it is dominated by non-pathogenic bacteria, then the system does not allow the expansion of pathogenic bacteria and prevents the infection development [2] . If there is a lack of some bacteria in the body, for example after antibiotic treatment, the body is more prone to be infected with pathogenic bacteria, fungi or viruses. Microorganisms, which are part of the microbiome, migrate to the child's body already during childbirth and, which is a new thing, they are very significant for further development [3] . Mice, which have grown in sterile conditions since birth, without a microbiome, develop very slowly and never reach the weight of animals with the correct microbiome [2] . Mother's milk contains sugars, which are not digested by the newborn, but are needed for the growth of appropriate bacteria [4] .
Bacteria come into contact with the central nervous system (CNS) in several ways [5, 6] . Microbiome affects learning processes, behaviour or a diet choice [7] . At different periods of life, the microbiome elements may have different functions affecting health and illness. For example, being infected with Helicobacter pylori in childhood (most frequently from the mother) protects against being infected with tuberculosis bacilli [8] and typhus bacilli [9] . Furthermore, being infected with these bacteria may prevent the development of multiple sclerosis in women [10] .
However, the long-lasting infection with these bacteria is responsible for atrophic gastritis and the development of stomach cancer [11] .
From a practical point of view, a one-time antibiotic treatment disturbs the microbiome functioning for a period of several years [12] . 12 Administration of morphine also disturbs the functioning of microbiome [13] , causing changes in the intestinal permeability barrier and in the passage of intestinal pathogens into the circulation. Many other drugs also inhibit the microbiome functioning. Exercises and physical exercise are very essential for the health of the microbiome and its ability to prevent infections [14] . The microbiome also undergoes changes along with physical exercises and with age. In the elderly, the bacterial flora may change from the commensal to the pathogenic one [15] .
Toll-like receptors
One of the ways the microbiome communicates with CNS is in the form of binding the lipopolysaccharides molecules (LPS) of bacterial origin with the pattern recognition receptors. These receptors detect potential pathogens (PAMP, Pathogen Associated Molecular Patterns), and compounds that might pose a threat to the body (DAMP, Danger Associated Molecular Patterns). Among these receptors, an important role is played by the transmembrane protein family, referred to as Toll-like (TL) receptors [16] , of which 13 types have been distinguished, including 10 types in humans. The TL receptors bind to a wide variety of compounds and proteins, wherein the ligands may enhance or inhibit these receptors. Stimulation of some TL receptors boosts the production of pro-inflammatory cytokines. 16 TL receptors are not very selective, and are not stereo-selective. Macrophages in the peripheral blood, on which these receptors are located, secrete pro-inflammatory cytokines IL-1b, IFN-g, and TNF-a under the influence of LPS contained in the typhoid vaccine [17] . 17 Activation of the TL receptors may also stimulate the production of anti-inflammatory cytokines [18] , which has the opposite effect. TL receptors, located on the CNS microglial cells, are responsible for the development of neurogenic inflammation, resulting in the occurrence of many symptoms [16] .
One of the TL receptor response to a viral infection is the production of interferon alpha (IFN-a), which is responsible for the destruction of viruses [19] . On the other hand, treatment of patients with IFN-a viral infection is associated with a significant risk of depression [19] . 19 It has been shown that infections may lead to inflammation in the nervous system, which is Zbigniew Żylicz, Immunology for palliative medicine specialists responsible for the development of depression [20] (see below). In addition to depression, the relationship between the neurogenic inflammation and the development of medical condition was described with regard to Parkinson's disease [21, 22] , multiple system atrophy [21] ,dementia [23] , Guillian-Barré syndrome [24] , multiple sclerosis [25] , and other atrophic diseases of the nervous system. The passive immunity system was associated with the growth of tumours, inter alia, of reproductive organs in women [26] , of large intestine [27] , lungs [28] and liver [29] .
Role of the innate immune system in the development of the disease symptoms
The most important for a palliative medicine specialist is participation of the innate immune system in the occurrence of symptoms, because knowledge in this area may allow the development of more effective treatment methods. Mechanisms of certain symptoms development will be discussed in more detail below.
Depression
The current data suggest that neurogenic inflammation that results from stress or an infection is the primary cause of depression development [30] . In patients with depression, the elevated levels of pro-inflammatory cytokines, acute phase proteins and adhesion molecules are found [21] . The presence of inflammation markers in the cerebrospinal fluid correlates with the severity of depression symptoms [32] [33] [34] . Additionally, as it has been mentioned, the therapeutic use of IFN-a in 50% of treated patients causes depression [35] . IFN-a is a potent inducer of pro-inflammatory cytokines: IL-6 and, to a lesser extent, IL-1b and TNF-a [35] . Interestingly, the symptoms of depression respond well to antidepressants from the group of selective serotonin reuptake inhibitors (SSRI) [36] . Depression induced by IFN-a treatment is associated with a change in serotonin metabolism caused by an increased activity of the indoleamine 2,3-dioxygenase enzyme, which metabolises tryptophan to kynurenine, and is subsequently metabolised to quinolinic acid [37] , which reduces the availability of serotonin typical of depression. Effective treatment of depression reduces the activity of pro-inflammatory cytokines [38] . Different antidepressants have different effects on TL receptors and result in other changes in the cytokine activity [39, 40] ; therefore, the change ("rotation") of antidepressants may be justified for this reason. It may be generally concluded that the SSRIs drug family inhibits the TL receptors and reduces the secretion of pro-inflammatory cytokines in this mechanism [41] .
Chronic and neuropathic pain
Until recently it was thought that the CNS cells other than neurons were only "auxiliary" or "supportive". In recent years, however, it has been proven that microglial cells, in particular the TL receptors located on them, which are responsible for the development of neurogenic inflammation, play an important role in the pathomechanism of chronic pain [42, 43] . The process of pain occurrence and chronification depends on central immune signalling that begins with the activation of TL receptors [44] . Since the activation of TL receptors (mainly TLR-2 and TLR-4) most frequently causes pro-inflammatory effects, they counteract the analgesic effect of opioids. Moreover, the activation of TL receptors may be responsible for such phenomena, as opioid-induced hyperalgesia, rapid development of tolerance to the analgesic effect, and opioid dependence [45, 46] . When considering the viewpoint of the analgesic therapy, it would be beneficial to inhibit the activation of TL receptors.
Until recently, opioids were thought to exert pharmacological effects only through μ, d, and k opioid receptors as evidenced by a reversal of opioid effects observed after the opioid receptor antagonist -naloxone -was administered. It is currently known that opioids also bind to TL receptors in the CNS, while TL receptors themselves are also inhibited by naloxone. The difference is, however, essential: TL receptors, in addition to opioids [45] , combine with many other compounds such as antidepressants [47] . The stereoselectivity of opioid receptors is another difference [48] . In nature, there are only left-handed (-) opioid isomers and only demonstrate the analgesic effect. The right-handed isomers (+) are synthesised in laboratories and constitute a sort of "side effect" of synthesis. However, TL receptors can be selectively blocked with (+) naloxone as this drug does not affect opioid receptors [49] . If TL demonstrated the anti-analgesic and pro-inflammatory effects, such blocking would be of a considerable benefit [50, 51] . An interesting experiment conducted in mice by Lewis et al. found that blocking TLR-2 and TLR-4 by administering (+)-naloxone is effective in the treatment of neuropathic pain [52] . Similar results were obtained by Mika et al [53] . The analgesic effect of buprenorphine in rats is increased when TL receptors become blocked [54] .
Neuropathic pain leads to the damage to the nervous tissue, especially on the surface of the sensory neurons responsible for the sensation of pain, and it involves, inter alia, TLR-2, TLR-3, TLR-4 and TLR-7. These receptors may be activated when the exogenous PAMPS (e.g. when a nerve is infected with the varicella-zoster virus) [55] and the endogenous DAMPS, released from the damaged tissues, become detected [56] . Additionally, TLR-4, the most important receptor in pain transmission, can be activated by glucuronides of hormones and drugs. TLR-4 is strongly activated by morphine-3-glucuronide, which leads to anti-analgesic effects associated with the production of pro-inflammatory cytokines [57] [58] [59] . Glucuronides of estrogens can also activate TLR-4, thus influencing different pain sensations in different sexes [60] .
TL receptors play an important role in the treatment of pain; yet, pro-nociceptive receptors are much more numerous. ATP is a very essential factor that works through P2X4 purine microglia receptors, which subsequently can activate TLR-4 [61] . In addition, P2X4 is the place where many non-opioid analgesics are held. Antidepressants such as paroxetine are potent inhibitors of the P2X4 receptors [62] . It seems likely that the above mechanism also causes the analgesic effect of tricyclic antidepressants in neuropathic pain.
Constipation
Opioids cause constipation by reacting with opioid receptors at the endings of entero-neurons in the gastrointestinal tract [63] . In addition to opioid receptors [64] , TLR-4 are also located at the same nerve endings [65] , the activation of which causes local inflammation and, as in irritable bowel syndrome [66] , causes intestinal motility disorders and constipation. Naloxone administered orally together with opioids may also demonstrate effects by blocking TL receptors [67, 68] . Future research may concern the role of specific TLR-4 inhibitors, e.g. (+)-naloxone in counteracting the development and treatment of constipation.
Fatigue
Fatigue is one of the very general and poorly understood symptoms accompanying many diseases, including autoimmune and neoplastic ones. For many years, fatigue has been associated with the activity of some inflammatory cytokines [69] , but recently a relationship between fatigue and an activation of TL receptors has been determined. The increased permeability of intestinal mucosa, characteristic of some diseases, causes a translocation of the Gram-negative bacteria and the LPS, derived from them, which results in the activation of the TL receptors that trigger the production of radicals and stimulate the inflammatory process [70] .
Pruritus
Pruritus is similar to pain in many respects; as in the case of pain, acute and chronic pruritus have been distinguished. Chronic pruritus can be divided into inflammatory and neuropathic [71] . Inflammatory pruritus depends on dermatitis, while the itching impulses usually originate from the circuit. At a later time, the activation of microglia and neurogenic inflammation play an important role in both inflammatory and neuropathic pruritus [72] . In the central neuro-inflammatory process (sensitisation), TL-2, TL-3 and TL-7 receptors are involved, which trigger the process of secretion of various cytokines [73, 74] . In the pro-nociceptive cascade, vanilloid receptors are also of considerable importance [75] . IL-31 was considered the most "pruriginous", but its role has not been defined so far [76, 77] . The role of P2X purine receptors in pruritus pathogenesis, which play an important role in the activation of TL-4 receptors [61] in neuropathic pain [78, 79] and possibly in neuropathic pruritus, also remains unclear, though there are no data concerning the latter.
In the course of neoplastic diseases inflammatory pruritus responds well to paroxetine, while in the course of cholestasis it responds to sertraline [80, 81] . Paroxetine and fluvoxamine are very effective in the treatment of chronic pruritus with dermatological symptoms (dermatitis) [82] . These drugs most strongly inhibit the development of neurogenic inflammation of microglia [83] . Additionally, paroxetine is considered a strong inhibitor of the P2X4 receptors [62] . It is yet to be established which drugs affect which receptors.
Cough
Cough can be divided into physiological: used to remove secretions and foreign bodies from the respiratory tract; and pathological: caused by the sensitisation of central centres, which may be continuous. A patient with such cough responds to slight changes in temperature or to the movement of air. Chronic, dry cough is similar to neuropathic pain [84] . Central cough centres may be sensitised after being infected with rhinoviruses, influenza viruses or tubercle bacilli [85, 86] , which cause coughing probably through the activation of TL receptors and an increased production of IF-g; the latter activates P2X4 purine receptors on microglial cells and causes neurogenic inflammation [87] . Interestingly, paroxetine strongly inhibits the P2X4 receptor [62] . Paroxetine strongly inhibits the reaction of TL receptors to bacterial LPS by inhibiting the secretion of pro-inflammatory cytokines in mice [41] . In 2004, several cases of patients with chronic cough, which responded to paroxetine or fluvoxamine very quickly, were described [88, 89] .
Opioids, including codeine, form the basis for the treatment of chronic cough. It has long been known that the receptor responsible for suppressing cough is not stereoselective. Cough reacts very well to right-handed derivatives of levorphanol, a strong opioid also referred to as dextromethorphan [90] , which binds to the TLR-4 receptor and, at least in vitro, causes its inhibition [45] .
Summary
Immunology is becoming a very important area that can explain the occurrence of many symptoms and, by identifying key receptors, suggest new, more effective methods for their treatment. The role of neurogenic inflammation in microglial cells is currently investigated in many studies. It seems that several groups of receptors are the anchor point of known and potentially new drugs. Interestingly, many of the symptoms difficult to treat in palliative medicine are characterised by a similar pathomechanism. A series of drugs, such as paroxetine affecting these processes, proved to be effective both in the treatment of depression [91] , pain [92] , pruritus [93] , and perhaps cough [89] . However, the possibility of influencing the above symptoms is not limited to SNRIs (selective noradrenaline reuptake inhibitors) and SSRIs. In these processes, the influx of calcium ions is very important, which is inhibited by gabapentin and pregabalin [94] -active in the treatment of many symptoms induced by central sensitisation [95] . Until recently, the development of new SSRIs was inhibited due to reports of an increased risk of suicide in adolescents [96, 97] . It seems, however, that further development of this group of drugs is possible, not only in the treatment of depression.
Streszczenie
Organizm ludzki ochraniany jest przed czynnikami szkodliwymi pochodzącymi ze świata zewnętrznego i wewnętrznego poprzez system odporności wrodzonej i nabytej, które współpracują ze sobą zarówno u osób zdrowych, jak i u chorych. Receptory Toll-like zlokalizowane są na powierzchni komórek mikrogleju i biorą udział w rozwoju zapalenia neurogennego, które z kolei prowadzi do wystąpienia wielu chorób i objawów, takich jak: depresja, zmęczenie, ból przewlekły i neuropatyczny, kaszel, zaparcie stolca i świąd. Aktywację receptorów Toll-like hamują między innymi leki przeciwdepresyjne. Prawdopodobnie w niedalekiej przyszłości poznane zostaną nowsze leki, skuteczniej hamujące rozwój zapalenia neurogennego, co pozwoli skuteczniej leczyć objawy oporne na standardową farmakoterapię.
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Słowa kluczowe: odporność wrodzona, odporność nabyta, mikroglej, receptory Toll-like, Pro-nocyceptywne cytokiny, zapalenie neurogenne Wstęp Do niedawna stwierdzenie, że specjalista medycyny paliatywnej powinien posiadać wiedzę w zakresie immunologii uważane byłoby za nieporozumienie. Nowoczesna immunologia z przeciwciałami monoklonalnymi i wieloma innymi bardzo drogimi, ale technologicznie zaawansowanymi procedurami, stanowiła w pewnym sensie zaprzeczenie zasad medycyny paliatywnej. Od pewnego czasu jednak immunolodzy starają się odpowiedzieć na pytania, które są bardzo interesujące dla specjalistów medycyny paliatywnej, mianowicie, w jaki sposób dochodzi do wystąpienia objawów choroby i w jaki sposób mogą być skuteczniej leczone. Niektóre leki znane są od dawna, jednak brakowało wiedzy dotyczącej mechanizmów ich działania. W okresie ostatnich 10 lat widoczny jest znaczny postęp w zakresie skuteczności leczenia objawów. Artykuł stanowi wprowadzenie do immunologii dla osób zainteresowanych medycyną paliatywną.
Rodzaje odporności
Organizm ludzki chroniony jest przed szkodliwymi wpływami z zewnętrz i wewnątrz przez dwa rodzaje systemów odpornościowych. Pierwszy to system
